The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream
CME accreditation pending for providers; Certificate of attendance available for both in-person and virtual attendees
Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance.
In a recent survey of Washington State healthcare providers, 70% reported treating patients experiencing severe abdominal pain, persistent nausea, retching, and relentless vomiting associated with heavy cannabis use.
Patients may not recognize cannabis as the cause of their symptoms, or may be skeptical that CHS exists at all, making effective care even more challenging.
Join the UW Addictions, Drug & Alcohol Institute (ADAI) on September 18, 2026, to for this FREE one-day symposium about:
What we know about CHS in Washington State and the U.S.—prevalence in hospitals, emergency departments, and community settings Recognition, diagnosis, treatment, and management across healthcare…
Event interval: Single day event. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Friday, September 18, 2026, 9:00 AM – 4:00 PM.
Virtual or at the UW Tower Auditorium (NE 45th St and Brooklyn Ave NE).
For more info visit adai.uw.edu. First Responder Wellness Summit: Caring for Ourselves During the Overdose Crisis
This free one-day summit brings together professionals from law enforcement, fire, EMS, corrections, co-response teams, dispatch, and peer support to explore how to strengthen first responder well-being amidst the current drug overdose crisis and in their lives more broadly.
Learn more about the speakers and breakout options here.
We have limited parking assistance funds available. If parking on campus would present a barrier to your attendance please indicate this during registration. Assistance will be provided on a first-come, first-served basis.
Contact nbranche@uw.edu for questions or for accommodation requests.
Event interval: Single day event. Accessibility Contact: Nicole Branche, nbranche@uw.edu. Event Types: Conferences.
Wednesday, September 23, 2026, 8:00 AM – 3:45 PM.
UW Student Union Building (HUB)
HUB Ballroom
4001 E. Stevens Way NE
Seattle, WA 98195.
For more info visit adai.uw.edu. Stabilizing High-Risk Pregnancy in OUD: A Two-Part Webinar on Inpatient Care (Part 1)
Opioid use disorder (OUD) in pregnancy is a high-risk pregnancy, and inpatient admission can be an appropriate, medically necessary means of stabilizing it. This two-part webinar presents both the clinical rationale for these stabilizing admissions and a practical framework for delivering them.
Part 1 establishes the clinical foundation, examining the maternal, obstetric, and neonatal risks associated with OUD in pregnancy; the role of medication for opioid use disorder (MOUD) in mitigating those risks; and the indications and medical necessity for admission. It also addresses a reimbursement misconception: that such admissions are made "to initiate MOUD," rather than to stabilize a high-risk pregnancy.
Part 2 translates this foundation into practice. In a moderated panel discussion, experienced clinicians share how stabilizing admissions are carried out across a range of care settings, offering case examples and lessons learned.
• Part 1: September 23 (12pm PT): Clinical Considerations for Admission
• Pa…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Target Audience: This series is intended for clinicians and health system professionals involved in the care of pregn.
Wednesday, September 23, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration.
Stabilizing High-Risk Pregnancy in OUD: A Two-Part Webinar on Inpatient Care (Part 2)
Opioid use disorder (OUD) in pregnancy is a high-risk pregnancy, and inpatient admission can be an appropriate, medically necessary means of stabilizing it. This two-part webinar presents both the clinical rationale for these stabilizing admissions and a practical framework for delivering them.
Part 1 establishes the clinical foundation, examining the maternal, obstetric, and neonatal risks associated with OUD in pregnancy; the role of medication for opioid use disorder (MOUD) in mitigating those risks; and the indications and medical necessity for admission. It also addresses a reimbursement misconception: that such admissions are made "to initiate MOUD," rather than to stabilize a high-risk pregnancy.
Part 2 translates this foundation into practice. In a moderated panel discussion, experienced clinicians share how stabilizing admissions are carried out across a range of care settings, offering case examples and lessons learned.
• Part 1 September 23 (12pm PT): Clinical Considerations for Admission
—Prese…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Target Audience: This series is intended for clinicians and health system professionals involved in the care of pregn.
Wednesday, October 21, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_hQOPOVq6QymAQqcdhUdqHw#/registration.
Frontline Conversations Series: 7-OH: Treatment Considerations for the New, More Potent Kratom
Join this 4-part webinar series, Frontline Conversations: Advancing SUD Care in Clinical Practice, facilitated by Mark Duncan, MD and Maureen Oscadal, RN, MPH, BSN, to explore emerging practices in the care of people living with substance use disorder (SUD).
This series features brief presentations and panel discussions with expert community providers on the topics listed below. A Q&A session for all participants will take place after the facilitated discussion.
November 4, 2026: 7-OH: Treatment Considerations for the New, More Potent Kratom
Panelists TBD!
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, November 4, 2026, 12:00 PM – 1:30 PM.
Webinar - register at: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration.